Reven Holdings Announces the Publication of a Peer-reviewed Article in the Prestigious Medical Journal Frontiers in Oncology
FirstWord Pharma,
Reven Holdings Also Reports That 12-patient Part 1 Completed Plus 10 Patients Already Enrolled and Dosed in Part 2 of the Double…